The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis

NCT03870841 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.

Conditions

Aspergillosis
Cystic Fibrosis

Interventions

DRUG: PC945

Sponsor

Pulmocide Ltd